Back to Search Start Over

Fibrolamellar Hepatocellular Carcinoma and Noncirrhotic Hyperammonemic Encephalopathy.

Authors :
Suarez O
Perez M
Garzon M
Daza R
Hernandez G
Salinas C
Ceballos J
de Leon EP
Mugnier J
Beltrán O
Varón A
Source :
Case reports in hepatology [Case Reports Hepatol] 2018 Dec 09; Vol. 2018, pp. 7521986. Date of Electronic Publication: 2018 Dec 09 (Print Publication: 2018).
Publication Year :
2018

Abstract

Fibrolamellar hepatocarcinoma is an infrequent liver tumor, currently considered to be a variant different from hepatocarcinoma. The differences lie in genomic alterations, a greater prevalence of fibrolamellar hepatocarcinoma in young patients, and its lack of association with underlying liver disease. The clinical presentation is unspecific, with symptoms ranging from abdominal pain, malaise, and weight loss to atypical manifestation which include hyperammonemic encephalopathy. We present the case of a 33-year-old woman with no prior medical history who presented with a coma and a diagnosis of inoperable fibrolamellar hepatocarcinoma requiring a cadaver donor transplant. While she was on the waiting list, she received hemofiltration and ammonium benzoate treatment, with progressive improvement in her state of consciousness.

Details

Language :
English
ISSN :
2090-6587
Volume :
2018
Database :
MEDLINE
Journal :
Case reports in hepatology
Publication Type :
Academic Journal
Accession number :
30631612
Full Text :
https://doi.org/10.1155/2018/7521986